RIBOMUSTIN 100 mg powder for concentrate for solution for infusion 100 mg Powder for concentrate for solution for infusion 60ml Vial 5pcs
Product Description
RIBOMUSTIN 100 mg powder for concentrate for solution for infusion is a potent chemotherapy medication used in the treatment of various hematological malignancies.
It is formulated to provide a precise dosage for intravenous administration, playing a crucial role in cancer therapy regimens.
This product is a prescription-only medicine and must be administered under the supervision of a qualified healthcare professional.
For more detailed information, please consult official pharmaceutical resources and your healthcare provider.
Benefits of Use
RIBOMUSTIN (Bendamustine hydrochloride) is highly effective in treating specific types of cancer.
It is indicated for chronic lymphocytic leukemia (CLL), indolent non-Hodgkin's lymphoma (NHL), and multiple myeloma.
The medication works by interfering with the DNA synthesis and repair processes in cancer cells, leading to their programmed cell death.
How to Use
RIBOMUSTIN 100 mg powder for concentrate for solution for infusion is for intravenous use only and should be prepared and administered by trained personnel.
1. Reconstitution: The powder must be reconstituted with sterile water for injection, followed by further dilution with an appropriate infusion solution (e.g., 0.9% sodium chloride).
2. Administration: The diluted solution is administered as an intravenous infusion over a specified period, as determined by the physician.
3. Dosage: Dosage and treatment duration are highly individualized based on the patient's condition, type of cancer, and response to therapy.
4. Monitoring: Patients receiving RIBOMUSTIN require close monitoring for adverse effects and treatment efficacy.
Caution & Warnings
RIBOMUSTIN can cause severe myelosuppression, including neutropenia, thrombocytopenia, and anemia. Complete blood counts should be monitored regularly.
Serious infections, including fatal cases, have been reported. Patients should be monitored for signs and symptoms of infection.
Severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, can occur. Discontinue treatment if severe skin reactions develop.
Hypersensitivity reactions, including anaphylaxis, may occur. Facilities for managing severe reactions should be available.
Tumor lysis syndrome may occur, especially in patients with a high tumor burden. Appropriate prophylactic measures should be taken.
RIBOMUSTIN can cause nausea, vomiting, fatigue, and other gastrointestinal disturbances.
This medication can cause fetal harm when administered to a pregnant woman. Women of childbearing potential should use effective contraception.
Avoid contact with skin and mucous membranes during preparation and administration. Use appropriate protective equipment.
Ingredients
Each vial contains 100 mg of Bendamustine hydrochloride.
Excipients: Mannitol.
Product Details
Strength: 100 mg per vial
Form: Powder for concentrate for solution for infusion
Package Size: 5 Vials
Manufacturer: Mundipharma
Storage: Store in a refrigerator (2C - 8C). Protect from light.
| Gtin | 1808222508 |
|---|---|
| Recommended Sale Price | 5196.75 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | BENDAMUSTINE HYDROCHLORIDE |
| SFDA Reg. No | 1808222508 |
| IBC | 1808222508 |
| Drug Type | Prescription |
| Scientific Name | Bendamustine hydrochloride |
| Strength | 100 |
| Strength Unit | mg |
| Form | Powder for concentrate for solution for infusion |
| Admin Route | Intravenous |
| Size | 60 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 5 Vials |
| Storage conditions | Store in a refrigerator (2C - 8C). Protect from light. |
| Refrigerator Storage | Yes |
